This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic…

Bipolar Disorder, Manic

~Estimated

~$10 – $8,750

Intra-Cellular Therapies, Inc.NCT06462586

Phase 3

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)

This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic…

Bipolar Disorder, Manic

~Estimated

~$10 – $8,750

Intra-Cellular Therapies, Inc.NCT06462612